Aug 2026· Advanced International Journal for Research· Vol 7· 0 citations· 29 references
TL;DR
Current strategies, namely molecular modification, crosslinking, surface shielding and structural optimization of PEI-based gene-delivery system are explored for enhancing the safety and therapeutic promise of this platform.
Abstract
Polyethylenimine (PEI) is a general-purpose polycationic polymer which has received much attention as a non-viral vector for therapeutic nucleic acid delivery in medicine. The high level of amine groups enables electrostatic complexation with negatively charged genetic material, leading to the formation of polyplex and higher cellular uptake. Once internalized, PEI can facilitate endosomal escape because of its buffering capacity and or its ability to destabilize cellular membranes, which promotes efficient delivery of DNA and RNA. Recent use of PEI-based systems for gene delivery (DNA and small interfering RNA) and other gene therapy and neurological applications are emphasized. The transfection efficiency is high, but clinical translation is hindered by its cytotoxicity and low biodegradability and systemic stability. Current strategies, namely molecular modification, crosslinking, surface shielding and structural optimization of PEI-based gene-delivery system are then explored for enhancing the safety and therapeutic promise of this platform. This review focuses on major forms of PEI, molecular structure, physicochemical properties influence gene-delivery performance and applications on non-viral gene delivery.
Gene delivery strategies include two main approaches: viral and nonviral systems to deliver the genetic material to target cells. Although viral vectors have high transfection efficacy, their clinical usage has been limited due to the risks of immunogenicity and mutagenesis. Therefore, nonviral delivery strategies such...
E. Çağlar, Emine Saldamlı· Methods in molecular biology· 0 citations
Gene delivery is a highly advanced therapeutic approach that involves introducing of therapeutic nucleic acids, including DNA and RNA, into target cells to restore, regulate, or enhance cellular function. Delivery vectors are a critical determinant of gene therapy efficacy and are generally classified as either viral o...
Houra Nekounam, Ali KarbalaeiMahdi, Faranak Mohammadi et al.· Nanotechnology· 0 citations
Gene therapy has found wide use in the prevention and treatment of cancer, infectious diseases, and neurodegenerative and metabolic disorders. Meanwhile, the development of formulations providing effective and targeted delivery of nucleic acids has been and remains a challenging interdisciplinary task. Polymeric system...
E. Shaputkin, I. Nifant'ev, P. Ivchenko· Russian Chemical Reviews· 0 citations
The development of polyplexes from natural or synthetic polycations and nucleic acids remains limited by intracellular barriers, which restrict efficient protein expression. A fundamental understanding of how polymer molecular design influences these processes is therefore essential. Here, we investigate the relationsh...
Paulina Alejandra Montaño González, M. Rochedy, Christophe Schatz et al.· Macromolecular Chemistry and...· 0 citations
This article reviews the recent progress and challenges associated with nano-based non-viral vectors designed for targeted delivery of DNA into cancerous cells.
M. Yousefian, Maryam Baharmast· Journal of Biomaterials Scie...· 0 citations
Cationic polymers have been widely studied as non-viral vectors for therapeutic nucleic acid delivery. This is because their chemical structure can be modified across molecular weight, charge density, composition, and overall architecture. These features determine how polymers interact with nucleic acids and with the b...
Joachim Emeka Arikibe, Anna Maria Mazzetta, Lisa Casagrande et al.· Open Research Europe· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.